Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11169953rdf:typepubmed:Citationlld:pubmed
pubmed-article:11169953lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C0062503lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C0007102lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:11169953lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:11169953pubmed:issue3lld:pubmed
pubmed-article:11169953pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11169953pubmed:abstractTextWe investigated the effect of hepatocyte-derived extracellular matrix (ECM) on the expression of erb-B2 and erb-B3 in colon cancer cell lines, as well as the role of erb-B2 and erb-B3 in colon cancer cell proliferation. Colon cancer cell lines plated on hepatocyte-derived ECM had increased protein levels of both erb-B2 and erb-B3. The addition of soluble recombinant proteoglycan syndecan-4 also resulted in higher expression of erb-B2 and erb-B3. We prepared hepatocyte-derived ECM from 1 to 7 days' cultures of hepatocytes, which contained different amounts of sulfated glycosaminoglycans. There was a direct correlation between the amounts of sulfated glycosaminoglycans in the ECM and the levels of erb-B2 and erb-B3 in the colon cell line KM12. The stimulatory effect of hepatocyte-derived ECM was abolished when the colon cancer cells were cultured in the presence of antibodies to erb-B2. These studies show that hepatocyte-derived ECM and the heparan sulfate proteoglycans present in it are responsible for inducing erb-B2 and erb-B3 in colon cancer cells. The growth stimulatory effect of extracellular matrix is mediated, at least in part, by increased expression of erb-B2 and erb-B3.lld:pubmed
pubmed-article:11169953pubmed:languageenglld:pubmed
pubmed-article:11169953pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:citationSubsetIMlld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11169953pubmed:statusMEDLINElld:pubmed
pubmed-article:11169953pubmed:monthFeblld:pubmed
pubmed-article:11169953pubmed:issn0020-7136lld:pubmed
pubmed-article:11169953pubmed:authorpubmed-author:BrillSSlld:pubmed
pubmed-article:11169953pubmed:authorpubmed-author:MoskovitzSSlld:pubmed
pubmed-article:11169953pubmed:authorpubmed-author:PapiEElld:pubmed
pubmed-article:11169953pubmed:authorpubmed-author:YayonAAlld:pubmed
pubmed-article:11169953pubmed:authorpubmed-author:HalpernZZlld:pubmed
pubmed-article:11169953pubmed:authorpubmed-author:ZvibelIIlld:pubmed
pubmed-article:11169953pubmed:issnTypePrintlld:pubmed
pubmed-article:11169953pubmed:day1lld:pubmed
pubmed-article:11169953pubmed:volume91lld:pubmed
pubmed-article:11169953pubmed:ownerNLMlld:pubmed
pubmed-article:11169953pubmed:authorsCompleteYlld:pubmed
pubmed-article:11169953pubmed:pagination316-21lld:pubmed
pubmed-article:11169953pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:meshHeadingpubmed-meshheading:11169953...lld:pubmed
pubmed-article:11169953pubmed:year2001lld:pubmed
pubmed-article:11169953pubmed:articleTitleSoluble and matrix-associated heparan sulfate proteoglycans increase expression of erb-B2 and erb-B3 in colon cancer cell lines.lld:pubmed
pubmed-article:11169953pubmed:affiliationLiver Metastasis Research Group, Gastroenterology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. isab@tasmc.health.gov.illld:pubmed
pubmed-article:11169953pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11169953pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed